NEW YORK (GenomeWeb) – The Worldwide Innovative Networking Consortium in personalized cancer medicine today announced the approval of six new members.

The new members are Asan Medical Center in South Korea; Cambridge Cancer Center in the UK; Cancer Research UK; CEO Roundtable on Cancer, headquartered in Cary, NC; the Kimmel Cancer Center at Jefferson in Philadelphia; and Memorial Sloan Kettering Cancer Center in New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.